|
|
|
|
ASRS annual meeting going virtual
|
 The American Society of Retina Specialists is the latest organization to announce its 2020 annual meeting will switch to a virtual format amid COVID-19 concerns.
|
|
Learn more
|
|
ADVERTISEMENT
|
|
|
|
|
|
COVID-19 implicated in conjunctivitis
|
 The COVID-19 virus can cause ocular complications such as conjunctivitis, though not necessarily in the early stages of the disease, according to researchers.
|
|
Read on
|
|
|
|
|
Caring for dry eye patients through the coronavirus pandemic
|
 Cynthia Matossian, MD, FACS, shares how her practice has continued to offer patient services via telemedicine appointments, common compliance issues she’s come across, and how to provide virtual care.
|
|
Read more
|
|
|
|
|
|
|
ADVERTISEMENT
|
|
|
| Earn CME Now
- Advances in the understanding of the pathophysiology of glaucoma and the recent US Food and Drug Administration approval of new treatment options are challenging traditional treatment paradigms, opening up new opportunities for physicians to improve visual outcomes for their patients with glaucoma. With these newer treatment options come new mechanisms of action, including nitric oxide’s effect on the trabecular meshwork and subsequent effects on aqueous humor outflow. More evidence-based data on the efficacy and safety of these drugs on lowering intraocular pressure are also available, and ophthalmologists who treat glaucoma must stay abreast of these developments in order to optimize patient outcomes. Participate now to learn ways to improve your practice in managing your patients with glaucoma.
Click here and earn 1.5 CME Credits
|
|
|
|
